Jule Taubmann

2.0k total citations · 2 hit papers
16 papers, 308 citations indexed

About

Jule Taubmann is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Jule Taubmann has authored 16 papers receiving a total of 308 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Jule Taubmann's work include CAR-T cell therapy research (9 papers), Biosimilars and Bioanalytical Methods (3 papers) and Viral Infectious Diseases and Gene Expression in Insects (3 papers). Jule Taubmann is often cited by papers focused on CAR-T cell therapy research (9 papers), Biosimilars and Bioanalytical Methods (3 papers) and Viral Infectious Diseases and Gene Expression in Insects (3 papers). Jule Taubmann collaborates with scholars based in Germany, Italy and Greece. Jule Taubmann's co-authors include Georg Schett, Andréas Mackensen, Fabian Müller, Dimitrios Mougiakakos, Michael Aigner, Simon Völkl, Franco Locatelli, Roberto Caricchio, Wei Wang and Aiden Haghikia and has published in prestigious journals such as Nature Medicine, Blood and Scientific Reports.

In The Last Decade

Jule Taubmann

15 papers receiving 304 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Advancements and challenges in CAR T cell therapy in autoimmune diseases

2024 85 citations Georg Schett, Fabian Müller et al. Nature Reviews Rheumatology profile →
BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cells

2025 15 citations Fabian Müller, Andreas Wirsching et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jule Taubmann Germany	9	176	99	98	41	41	16	308
Juan Esteban García-Robledo United States	9	102 0.6×	77 0.8×	68 0.7×	30 0.7×	23 0.6×	33	266
Sasan Ghaffari Iran	10	123 0.7×	84 0.8×	117 1.2×	15 0.4×	40 1.0×	21	309
Jasper F. Nies Germany	6	118 0.7×	121 1.2×	110 1.1×	36 0.9×	45 1.1×	11	309
Matteo Doglio Italy	8	150 0.9×	116 1.2×	50 0.5×	28 0.7×	30 0.7×	19	245
Gonzalo Carreño‐Tarragona Spain	9	94 0.5×	107 1.1×	81 0.8×	13 0.3×	19 0.5×	32	290
Ira L. Kraft United States	9	130 0.7×	43 0.4×	77 0.8×	16 0.4×	68 1.7×	19	295
Naomi Porret Switzerland	11	157 0.9×	39 0.4×	130 1.3×	60 1.5×	46 1.1×	41	440
Mohamed Aziz United States	9	193 1.1×	122 1.2×	80 0.8×	7 0.2×	15 0.4×	15	356
Luis Gerardo Rodríguez‐Lobato Spain	13	221 1.3×	155 1.6×	244 2.5×	8 0.2×	33 0.8×	48	493
J.A. Vidart Spain	9	110 0.6×	51 0.5×	62 0.6×	29 0.7×	22 0.5×	25	347

Countries citing papers authored by Jule Taubmann

Since Specialization

Citations

This map shows the geographic impact of Jule Taubmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jule Taubmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jule Taubmann more than expected).

Fields of papers citing papers by Jule Taubmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jule Taubmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jule Taubmann. The network helps show where Jule Taubmann may publish in the future.

Co-authorship network of co-authors of Jule Taubmann

This figure shows the co-authorship network connecting the top 25 collaborators of Jule Taubmann. A scholar is included among the top collaborators of Jule Taubmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jule Taubmann. Jule Taubmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Albrecht, A., Jule Taubmann, Ioanna Minopoulou, et al.. (2025). Real-World-Evidence of Digital Health Applications (DiGAs) in Rheumatology: Insights from the DiGAReal Registry. Rheumatology and Therapy. 12(2). 267–282. 5 indexed citations

Müller, Fabian, Andreas Wirsching, Melanie Hagen, et al.. (2025). BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cells. Nature Medicine. 31(6). 1793–1797. 15 indexed citations breakdown →

Taubmann, Jule, Sebastian Boeltz, Melanie Hagen, et al.. (2025). Langzeitverlauf von Effizienz und Sicherheit der CD19-CAR T-Zell-Therapie beim systemischen Lupus erythematodes. Zeitschrift für Rheumatologie. 84(8). 612–620. 1 indexed citations

Garantziotis, Panagiotis, Julius Lindblom, Dionysis Nikolopoulos, et al.. (2025). DISTINCT MOLECULAR PROFILES OF REMISSION POST-CD19 CAR-T CELL THERAPY VERSUS STANDARD IMMUNOSUPPRESSION IN SYSTEMIC LUPUS ERYTHEMATOSUS. The Journal of Rheumatology. 52(Suppl 1). 8–8.

Taubmann, Jule, Christina Bergmann, Johannes Knitza, et al.. (2025). Exploring CAR T-Cell Dynamics: Balancing Potent Cytotoxicity and Controlled Inflammation in CAR T-Cells Derived from Systemic Sclerosis and Myositis Patients. International Journal of Molecular Sciences. 26(2). 467–467. 3 indexed citations

Schett, Georg, Fabian Müller, Jule Taubmann, et al.. (2024). Advancements and challenges in CAR T cell therapy in autoimmune diseases. Nature Reviews Rheumatology. 20(9). 531–544. 85 indexed citations breakdown →

Hagen, Melanie, Andreas Wirsching, Jule Taubmann, et al.. (2024). CAR-T-Zell-Therapie in der Rheumatologie – Was wissen wir bisher?. Zeitschrift für Rheumatologie. 83(6). 485–491. 1 indexed citations

Aigner, Michael, Jule Taubmann, Ioanna Minopoulou, et al.. (2024). Fully Human Anti-CD19 CAR T Cells Derived from Systemic Lupus Erythematosus Patients Exhibit Cytotoxicity with Reduced Inflammatory Cytokine Production. Transplantation and Cellular Therapy. 30(6). 582.e1–582.e10. 9 indexed citations

Labinsky, Hannah, F Hartmann, Katharina Otani, et al.. (2023). An AI-Powered Clinical Decision Support System to Predict Flares in Rheumatoid Arthritis: A Pilot Study. Diagnostics. 13(1). 148–148. 19 indexed citations

10.

Taubmann, Jule, Fabian Müller, Simon Völkl, et al.. (2023). CD19 Chimeric Antigen Receptor T Cell Treatment: Unraveling the Role of B Cells in Systemic Lupus Erythematosus. Arthritis & Rheumatology. 76(4). 497–504. 37 indexed citations

11.

Taubmann, Jule, Johannes Knitza, Fabian Müller, et al.. (2023). Rescue therapy of antisynthetase syndrome with CD19-targeted CAR-T cells after failure of several B-cell depleting antibodies. Lara D. Veeken. 63(1). e12–e14. 55 indexed citations

12.

Taubmann, Jule, Johannes Knitza, Fabian Müller, et al.. (2023). Comment on: Rescue therapy of anti-synthetase syndrome with CD19-targeted CART cells after failure of several B cell–depleting antibodies: reply. Lara D. Veeken. 63(11). e312–e314. 2 indexed citations

13.

Taubmann, Jule, Simon Voelkl, Laura Bucci, et al.. (2023). CD19-Targeted CAR-T Cells in Refractory Systemic Autoimmune Diseases: A Monocentric Experience from the First Fifteen Patients. Blood. 142(Supplement 1). 220–220. 9 indexed citations

14.

Taubmann, Jule, Jochen Wacker, Koray Taşçılar, et al.. (2022). Neutralizing monoclonal antibodies against SARS-CoV-2 for COVID-19 pneumonia in a rituximab treated patient with systemic sclerosis—A case report and literature review. Frontiers in Medicine. 9. 934169–934169. 1 indexed citations

15.

Stoll, Cornelia, Katrin Palumbo‐Zerr, Christina Böhm, et al.. (2020). PPARδ-mediated mitochondrial rewiring of osteoblasts determines bone mass. Scientific Reports. 10(1). 8428–8428. 19 indexed citations

16.

Taubmann, Jule, Brenda Krishnacoumar, Christina Böhm, et al.. (2020). Metabolic reprogramming of osteoclasts represents a therapeutic target during the treatment of osteoporosis. Scientific Reports. 10(1). 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact